At present, other immunotherapies such as adoptive cell therapy, monoclonal antibodies, oncolytic viruses, and immune system regulators have shown efficacy in various types of cancer; however, their efficacy needs to be explored in combination with WT p53 reactivation therapy. This evidence concerns the gene TP53 and cancer.